# Allopregnanolone for the Treatment of Traumatic Brain Injury

> **NCT01673828** · PHASE2 · COMPLETED · sponsor: **Michael A. Rogawski, MD, PhD** · enrollment: 13 (actual)

## Conditions studied

- Traumatic Brain Injury
- Posttraumatic Epilepsy

## Interventions

- **DRUG:** Allopregnanolone injection
- **DRUG:** Placebo injection

## Key facts

- **NCT ID:** NCT01673828
- **Lead sponsor:** Michael A. Rogawski, MD, PhD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2015-05
- **Final completion:** 2016-07
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2017-06-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01673828

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01673828, "Allopregnanolone for the Treatment of Traumatic Brain Injury". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01673828. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*